Breaking News Instant updates and real-time market news.

FERG

Ferguson

$118.22 /

+2.85 (+2.47%)

14:48
05/12/22
05/12
14:48
05/12/22
14:48

Ferguson price target lowered to 10,365 GBp from 11,475 GBp at Credit Suisse

Credit Suisse analyst Emily Biddulph lowered the firm's price target on Ferguson to 10,365 GBp from 11,475 GBp and keeps a Neutral rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Periodicals
Merck in advanced talks to buy Seagen for $40B+, WSJ reports » 05:50
07/07/22
07/07
05:50
07/07/22
05:50
MRK

Merck

$93.16 /

+0.52 (+0.56%)

, SGEN

Seagen

$175.15 /

-1.78 (-1.01%)

Merck (MRK) is in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$93.16 /

+0.52 (+0.56%)

SGEN Seagen
$175.15 /

-1.78 (-1.01%)

MRK Merck
$93.16 /

+0.52 (+0.56%)

05:10 Today Daiwa
Merck upgraded to Outperform from Neutral at Daiwa (yesterday)
07/06/22 Daiwa
Merck upgraded to Buy from Neutral at Daiwa
06/29/22 Raymond James
Seagen initiated with an Outperform at Raymond James
06/28/22 Piper Sandler
Sutro Biopharma price target raised to $16 from $14 at Piper Sandler
SGEN Seagen
$175.15 /

-1.78 (-1.01%)

06/29/22 Raymond James
Seagen initiated with an Outperform at Raymond James
06/28/22 Piper Sandler
Sutro Biopharma price target raised to $16 from $14 at Piper Sandler
06/27/22 Cowen
Merck price target raised to $102 from $95 at Cowen
06/24/22 Mizuho
Merck deal would add 'novel and validated technology,' says Mizuho
MRK Merck
$93.16 /

+0.52 (+0.56%)

SGEN Seagen
$175.15 /

-1.78 (-1.01%)

MRK Merck
$93.16 /

+0.52 (+0.56%)

SGEN Seagen
$175.15 /

-1.78 (-1.01%)

MRK Merck
$93.16 /

+0.52 (+0.56%)

SGEN Seagen
$175.15 /

-1.78 (-1.01%)

MRK Merck
$93.16 /

+0.52 (+0.56%)

Periodicals
Microsoft cloud exec leaving after allegations of verbal abuse, Bloomberg says » 05:48
07/07/22
07/07
05:48
07/07/22
05:48
MSFT

Microsoft

$266.22 /

+3.35 (+1.27%)

Tom Keane, a Microsoft VP…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$266.22 /

+3.35 (+1.27%)

MSFT Microsoft
$266.22 /

+3.35 (+1.27%)

07/06/22 Needham
RingCentral downgraded to Hold from Buy at Needham
06/29/22 Redburn
Microsoft initiated with a Buy at Redburn
06/27/22 William Blair
Okta not seeing backlash from security breach, says William Blair
06/24/22 Citi
Citi names top software picks with sector de-rating 'mostly done'
MSFT Microsoft
$266.22 /

+3.35 (+1.27%)

MSFT Microsoft
$266.22 /

+3.35 (+1.27%)

MSFT Microsoft
$266.22 /

+3.35 (+1.27%)

MSFT Microsoft
$266.22 /

+3.35 (+1.27%)

Upgrade
1Life Healthcare upgraded to Buy from Neutral at BTIG » 05:47
07/07/22
07/07
05:47
07/07/22
05:47
ONEM

1Life Healthcare

$10.29 /

-0.07 (-0.68%)

, CVS

CVS Health

$93.20 /

+0.67 (+0.72%)

, UNH

UnitedHealth

$515.28 /

+10.54 (+2.09%)

, ELV

Elevance Health

$484.65 /

+8.295 (+1.74%)

BTIG analyst David Larsen…

BTIG analyst David Larsen upgraded 1Life Healthcare (ONEM) to Buy from Neutral with a $15 price target. Over the past two years, the stock has traded down from $60 to $10, making the multiple "far more reasonable now than it has been in the past," Larsen tells investors in a research note. The analyst also believes that the odds of 1Life being acquired are "fairly high." While the stock rallied 25% on July 5 following a Bloomberg article discussing a possible takeout, 1Life has further valuation upside potential driven by improving Medicare margins, steady membership and revenue growth, cross-sales between Medicare and Commercial, an abatement of COVID, and "well-managed" expectations, contends Larsen. He believes potential acquirers of the business include CVS Health (CVS), a large health plan such as UnitedHealth Group (UNH) or Elevance Health (ELV), or possibly a large publicly traded hospital system. A strategic takeout "seems a very real possibility," writes Larsen.

ShowHide Related Items >><<
ONEM 1Life Healthcare
$10.29 /

-0.07 (-0.68%)

CVS CVS Health
$93.20 /

+0.67 (+0.72%)

UNH UnitedHealth
$515.28 /

+10.54 (+2.09%)

ELV Elevance Health
$484.65 /

+8.295 (+1.74%)

ONEM 1Life Healthcare
$10.29 /

-0.07 (-0.68%)

07/06/22 Deutsche Bank
1Life would not check 'earnings box' for CVS, says Deutsche Bank
07/06/22 Citi
Citi not seeing 'wide buyer universe' for 1Life outside of CVS
07/05/22 Stifel
Stifel says 'logical to assume' Walgreens could look at 1Life Healthcare
06/16/22 Deutsche Bank
1Life Healthcare market cap now below last private raise, says Deutsche Bank
CVS CVS Health
$93.20 /

+0.67 (+0.72%)

07/06/22 Deutsche Bank
1Life would not check 'earnings box' for CVS, says Deutsche Bank
07/06/22 Citi
Citi not seeing 'wide buyer universe' for 1Life outside of CVS
07/05/22 Stifel
Stifel says 'logical to assume' Walgreens could look at 1Life Healthcare
06/16/22 Loop Capital
Loop Capital starts CVS Health at Buy citing position to capitalize on Medicare
UNH UnitedHealth
$515.28 /

+10.54 (+2.09%)

07/05/22 Stifel
Stifel says 'logical to assume' Walgreens could look at 1Life Healthcare
06/16/22 Loop Capital
Loop starts UnitedHealth at Buy, sees company having 'major' advantages
06/16/22 Loop Capital
UnitedHealth initiated with a Buy at Loop Capital
06/01/22 Citi
Change Healthcare price target raised to $27.75 from $25.75 at Citi
ELV Elevance Health
$484.65 /

+8.295 (+1.74%)

ONEM 1Life Healthcare
$10.29 /

-0.07 (-0.68%)

CVS CVS Health
$93.20 /

+0.67 (+0.72%)

UNH UnitedHealth
$515.28 /

+10.54 (+2.09%)

ONEM 1Life Healthcare
$10.29 /

-0.07 (-0.68%)

CVS CVS Health
$93.20 /

+0.67 (+0.72%)

UNH UnitedHealth
$515.28 /

+10.54 (+2.09%)

ONEM 1Life Healthcare
$10.29 /

-0.07 (-0.68%)

CVS CVS Health
$93.20 /

+0.67 (+0.72%)

UNH UnitedHealth
$515.28 /

+10.54 (+2.09%)

ONEM 1Life Healthcare
$10.29 /

-0.07 (-0.68%)

CVS CVS Health
$93.20 /

+0.67 (+0.72%)

UNH UnitedHealth
$515.28 /

+10.54 (+2.09%)

Periodicals
Shell still investing in Gulf amid climate, political debate, WSJ reports » 05:46
07/07/22
07/07
05:46
07/07/22
05:46
SHEL

Shell

$48.00 /

-0.585 (-1.20%)

, EQNR

Equinor

$32.88 /

-0.64 (-1.91%)

Shell (SHEL) is investing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHEL Shell
$48.00 /

-0.585 (-1.20%)

EQNR Equinor
$32.88 /

-0.64 (-1.91%)

SHEL Shell
$48.00 /

-0.585 (-1.20%)

07/06/22 Deutsche Bank
Shell price target raised to 2,779 GBp from 2,551 GBp at Deutsche Bank
06/09/22 Credit Suisse
Shell initiated with an Outperform at Credit Suisse
05/11/22 Morgan Stanley
Shell price target raised to 2,860 GBp from 2,570 GBp at Morgan Stanley
05/06/22 UBS
Shell price target raised to 2,550 GBp from 2,450 GBp at UBS
EQNR Equinor
$32.88 /

-0.64 (-1.91%)

07/06/22 Deutsche Bank
Equinor price target raised to NOK 354 from NOK 314 at Deutsche Bank
06/17/22 JPMorgan
Equinor upgraded to Neutral from Underweight at JPMorgan
06/09/22 Credit Suisse
Equinor initiated with a Neutral at Credit Suisse
05/20/22 Societe Generale
Equinor downgraded to Hold from Buy at Societe Generale
SHEL Shell
$48.00 /

-0.585 (-1.20%)

SHEL Shell
$48.00 /

-0.585 (-1.20%)

EQNR Equinor
$32.88 /

-0.64 (-1.91%)

SHEL Shell
$48.00 /

-0.585 (-1.20%)

EQNR Equinor
$32.88 /

-0.64 (-1.91%)

SHEL Shell
$48.00 /

-0.585 (-1.20%)

EQNR Equinor
$32.88 /

-0.64 (-1.91%)

Initiation
EyePoint initiated with a Buy at Chardan » 05:43
07/07/22
07/07
05:43
07/07/22
05:43
EYPT

EyePoint

$7.78 /

-0.02 (-0.26%)

Chardan analyst Daniil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYPT EyePoint
$7.78 /

-0.02 (-0.26%)

EYPT EyePoint
$7.78 /

-0.02 (-0.26%)

11/16/21 Cantor Fitzgerald
EyePoint stock movement unwarranted, says Cantor Fitzgerald
11/15/21 Cowen
EyePoint price target raised to $35 from $25 at Cowen
11/15/21 Cowen
EyePoint price target raised to $35 from $25 at Cowen
11/15/21 Guggenheim
EyePoint price target raised to $75 from $22 at Guggenheim
EYPT EyePoint
$7.78 /

-0.02 (-0.26%)

  • 17
    Nov
Upgrade
AngloGold Ashanti upgraded to Buy from Hold at Investec » 05:37
07/07/22
07/07
05:37
07/07/22
05:37
AU

AngloGold Ashanti

$14.75 /

+0.27 (+1.87%)

Investec analyst Herbert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AU AngloGold Ashanti
$14.75 /

+0.27 (+1.87%)

AU AngloGold Ashanti
$14.75 /

+0.27 (+1.87%)

06/29/22 Deutsche Bank
AngloGold Ashanti price target lowered to $21 from $25 at Deutsche Bank
03/10/22 Deutsche Bank
AngloGold Ashanti price target raised to $28 from $24 at Deutsche Bank
03/07/22 JPMorgan
AngloGold Ashanti upgraded to Overweight from Neutral at JPMorgan
03/01/22 Investec
AngloGold Ashanti upgraded to Hold from Sell at Investec
Downgrade
Anglo American downgraded to Hold from Buy at Investec » 05:36
07/07/22
07/07
05:36
07/07/22
05:36
NGLOY

Anglo American

$15.87 /

+ (+0.00%)

Investec analyst Nkateko…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NGLOY Anglo American
$15.87 /

+ (+0.00%)

07/05/22 JPMorgan
Anglo American price target raised to 3,800 GBp from 3,350 GBp at JPMorgan
06/29/22 Deutsche Bank
Anglo American downgraded to Hold from Buy at Deutsche Bank
06/23/22 Morgan Stanley
Anglo American price target lowered to 3,400 GBp at Morgan Stanley
06/22/22 JPMorgan
Anglo American price target lowered to 3,350 GBp from 3,450 GBp at JPMorgan
Downgrade
Sibanye Stillwater downgraded to Hold from Buy at Investec » 05:36
07/07/22
07/07
05:36
07/07/22
05:36
SBSW

Sibanye Stillwater

$10.05 /

+0.1 (+1.01%)

Investec analyst Nkateko…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBSW Sibanye Stillwater
$10.05 /

+0.1 (+1.01%)

SBSW Sibanye Stillwater
$10.05 /

+0.1 (+1.01%)

06/29/22 Deutsche Bank
Sibanye Stillwater price target lowered to $14 from $17 at Deutsche Bank
06/01/22 RBC Capital
RBC Capital cuts Sibanye Stillwater to Sector Perform on challenging environment
06/01/22 RBC Capital
Sibanye Stillwater downgraded to Sector Perform from Outperform at RBC Capital
05/09/22 Goldman Sachs
Sibanye Stillwater initiated with a Buy at Goldman Sachs
SBSW Sibanye Stillwater
$10.05 /

+0.1 (+1.01%)

Downgrade
Impala Platinum downgraded to Hold from Buy at Investec » 05:35
07/07/22
07/07
05:35
07/07/22
05:35
IMPUY

Impala Platinum

$10.58 /

-0.28 (-2.58%)

Investec analyst Nkateko…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMPUY Impala Platinum
$10.58 /

-0.28 (-2.58%)

05/09/22 Goldman Sachs
Impala Platinum initiated with a Neutral at Goldman Sachs
11/17/21 Morgan Stanley
Impala Platinum upgraded to Overweight from Equal Weight at Morgan Stanley
Upgrade
Gold Fields upgraded to Buy from Hold at Investec » 05:34
07/07/22
07/07
05:34
07/07/22
05:34
GFI

Gold Fields

$9.02 /

+0.08 (+0.90%)

Investec analyst Herbert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GFI Gold Fields
$9.02 /

+0.08 (+0.90%)

GFI Gold Fields
$9.02 /

+0.08 (+0.90%)

04/04/22 JPMorgan
Gold Fields downgraded to Neutral from Overweight at JPMorgan
03/21/22 UBS
UBS starts Gold Fields with Sell, says benefit's priced in
03/21/22 UBS
Gold Fields initiated with a Sell at UBS
03/17/22 BMO Capital
Gold Fields downgraded to Market Perform from Outperform at BMO Capital
GFI Gold Fields
$9.02 /

+0.08 (+0.90%)

Downgrade
Freee downgraded to Neutral from Outperform at Macquarie » 05:33
07/07/22
07/07
05:33
07/07/22
05:33
FREKF

Freee

$26.00 /

+ (+0.00%)

Macquarie analyst Hiroshi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FREKF Freee
$26.00 /

+ (+0.00%)

10/22/21 Credit Suisse
Freee downgraded to Neutral from Outperform at Credit Suisse
09/01/21 Citi
Freee downgraded to Neutral from Buy at Citi
Upgrade
Cerence upgraded to Sector Perform from Underperform at RBC Capital » 05:32
07/07/22
07/07
05:32
07/07/22
05:32
CRNC

Cerence

$25.75 /

-0.385 (-1.47%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRNC Cerence
$25.75 /

-0.385 (-1.47%)

CRNC Cerence
$25.75 /

-0.385 (-1.47%)

05/18/22 Northland
SoundHound replacing Cerence at Hyundai, says Northland
05/11/22 Craig-Hallum
Cerence price target lowered to $45 from $52 at Craig-Hallum
05/11/22 Wedbush
Cerence price target lowered to $32 from $45 at Wedbush
02/21/22 Goldman Sachs
Cerence downgraded to Neutral from Buy at Goldman Sachs
CRNC Cerence
$25.75 /

-0.385 (-1.47%)

CRNC Cerence
$25.75 /

-0.385 (-1.47%)

Initiation
Kalera initiated with a Buy at Roth Capital » 05:28
07/07/22
07/07
05:28
07/07/22
05:28
KAL

Kalera

$4.34 /

+1.54 (+55.00%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KAL Kalera
$4.34 /

+1.54 (+55.00%)

Upgrade
Orkla upgraded to Buy from Hold at Nordea » 05:25
07/07/22
07/07
05:25
07/07/22
05:25
ORKLY

Orkla

$8.04 /

+0.02 (+0.25%)

Nordea analyst Kristoffer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORKLY Orkla
$8.04 /

+0.02 (+0.25%)

05/19/22 Bernstein
Orkla upgraded to Outperform from Market Perform at Bernstein
05/09/22 Kepler Cheuvreux
Orkla upgraded to Buy from Hold at Kepler Cheuvreux
04/08/22 Nordea
Orkla downgraded to Hold from Buy at Nordea
04/05/22 UBS
Orkla price target lowered to NOK 73 from NOK 76 at UBS
Downgrade
Boston Beer downgraded to Sector Perform from Outperform at RBC Capital » 05:25
07/07/22
07/07
05:25
07/07/22
05:25
SAM

Boston Beer

$306.38 /

-10.87 (-3.43%)

RBC Capital analyst Nik…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAM Boston Beer
$306.38 /

-10.87 (-3.43%)

SAM Boston Beer
$306.38 /

-10.87 (-3.43%)

06/28/22 Goldman Sachs
Boston Beer downgraded to Sell from Neutral at Goldman Sachs
06/22/22 Bernstein
Bernstein downgrades Boston Beer to Market Perform, lowers price target to $340
06/22/22 Bernstein
Boston Beer downgraded to Market Perform from Outperform at Bernstein
06/21/22 UBS
Boston Beer downgraded to Neutral from Buy at UBS
SAM Boston Beer
$306.38 /

-10.87 (-3.43%)

SAM Boston Beer
$306.38 /

-10.87 (-3.43%)

SAM Boston Beer
$306.38 /

-10.87 (-3.43%)

Upgrade
Trainline upgraded to Buy from Hold at Panmure Gordon » 05:23
07/07/22
07/07
05:23
07/07/22
05:23
TNLIF

Trainline

$3.64 /

+ (+0.00%)

Panmure Gordon analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TNLIF Trainline
$3.64 /

+ (+0.00%)

05/27/22 JPMorgan
Trainline price target lowered to 292 GBp from 307 GBp at JPMorgan
05/06/22 Deutsche Bank
Trainline price target raised to 319 GBp from 268 GBp at Deutsche Bank
05/06/22 Morgan Stanley
Trainline price target raised to 310 GBp from 270 GBp at Morgan Stanley
05/06/22 JPMorgan
Trainline price target raised to 307 GBp from 235 GBp at JPMorgan
Initiation
Indus Holding initiated with an Outperform at Oddo BHF » 05:23
07/07/22
07/07
05:23
07/07/22
05:23
INDHF

Indus Holding

$43.00 /

+ (+0.00%)

Oddo BHF initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Consolidated Communications downgraded to Sell from Neutral at Citi » 05:19
07/07/22
07/07
05:19
07/07/22
05:19
CNSL

Consolidated Communications

$6.98 /

-0.235 (-3.26%)

Citi analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNSL Consolidated Communications
$6.98 /

-0.235 (-3.26%)

CNSL Consolidated Communications
$6.98 /

-0.235 (-3.26%)

03/08/22 Citi
Consolidated Communications upgraded to Neutral from Sell at Citi
03/04/22 Wells Fargo
Consolidated Communications downgraded to Equal Weight from Overweight at Wells Fargo
03/04/22 Citi
Consolidated Communications downgraded to Sell from Neutral at Citi
10/29/21 Citi
Consolidated Communications upgraded to Neutral from Sell at Citi
CNSL Consolidated Communications
$6.98 /

-0.235 (-3.26%)

CNSL Consolidated Communications
$6.98 /

-0.235 (-3.26%)

Hot Stocks
Cognizant extends relationship with Zurich Beteiligungs-AG » 05:12
07/07/22
07/07
05:12
07/07/22
05:12
CTSH

Cognizant

$68.02 /

+0.28 (+0.41%)

Cognizant announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$68.02 /

+0.28 (+0.41%)

CTSH Cognizant
$68.02 /

+0.28 (+0.41%)

05/09/22 Cowen
Cognizant price target lowered to $95 from $98 at Cowen
05/05/22 Citi
Cognizant price target lowered to $88 from $95 at Citi
02/07/22 Barclays
Cognizant price target raised to $85 from $78 at Barclays
02/03/22 BMO Capital
Cognizant price target raised to $100 from $92 at BMO Capital
CTSH Cognizant
$68.02 /

+0.28 (+0.41%)

CTSH Cognizant
$68.02 /

+0.28 (+0.41%)

Hot Stocks
Exelixis, Ryvu enter exclusive license agreement for STING technology » 05:10
07/07/22
07/07
05:10
07/07/22
05:10
EXEL

Exelixis

$21.55 /

-0.685 (-3.08%)

Exelixis and Ryvu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXEL Exelixis
$21.55 /

-0.685 (-3.08%)

EXEL Exelixis
$21.55 /

-0.685 (-3.08%)

06/23/22 BMO Capital
Exelixis initiated with an Outperform at BMO Capital
05/19/22 Piper Sandler
Exelixis sold off on Cabometyx patent trial comments, says Piper Sandler
05/19/22 Truist
Exelixis should be bought on dip caused by '776 patent worries, says Truist
05/12/22 Jefferies
Exelixis could approach $26-$28 if it settles or wins MSN trial, says Jefferies
EXEL Exelixis
$21.55 /

-0.685 (-3.08%)

EXEL Exelixis
$21.55 /

-0.685 (-3.08%)

Upgrade
Merck upgraded to Outperform from Neutral at Daiwa (yesterday) » 05:10
07/07/22
07/07
05:10
07/07/22
05:10
MRK

Merck

$93.16 /

+0.52 (+0.56%)

Daiwa analyst Narumi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$93.16 /

+0.52 (+0.56%)

MRK Merck
$93.16 /

+0.52 (+0.56%)

07/06/22 Daiwa
Merck upgraded to Buy from Neutral at Daiwa
06/29/22 Raymond James
Seagen initiated with an Outperform at Raymond James
06/28/22 Piper Sandler
Sutro Biopharma price target raised to $16 from $14 at Piper Sandler
06/27/22 Cowen
Merck price target raised to $102 from $95 at Cowen
MRK Merck
$93.16 /

+0.52 (+0.56%)

MRK Merck
$93.16 /

+0.52 (+0.56%)

MRK Merck
$93.16 /

+0.52 (+0.56%)

MRK Merck
$93.16 /

+0.52 (+0.56%)

Hot Stocks
Hive Blockchain produces 278.5 Bitcoin in June » 05:08
07/07/22
07/07
05:08
07/07/22
05:08
HIVE

Hive Blockchain

$3.23 /

-0.155 (-4.59%)

, BTC

Bitcoin

/

+

, $BTC

Bitcoin

/

+

, BITCOIN

Bitcoin

/

+

, $ETH

Ethereum

/

+

Hive Blockchain announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTC Bitcoin
/

+

$BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

$ETH Ethereum
/

+

HIVE Hive Blockchain
$3.23 /

-0.155 (-4.59%)

03/25/22 Canaccord
Hive Blockchain initiated with a Buy at Canaccord
03/24/22 Stifel
Hive Blockchain initiated with a Speculative Buy at Stifel
01/03/22 H.C. Wainwright
Hive Blockchain price target raised to $5 from $4 at H.C. Wainwright
BTC Bitcoin
/

+

07/06/22 Atlantic Equities
Atlantic downgrades Coinbase to Neutral, lowers price target 'materially'
06/28/22 Compass Point
Compass Point upgrades Riot Blockchain to Buy while halving price target
06/23/22 B. Riley
Marathon Digital downgraded to Neutral at B. Riley amid sharp decline in Bitcoin
06/13/22 Morgan Stanley
Ethereum weakening faster than bitcoin, says Morgan Stanley
$BTC Bitcoin
/

+

07/06/22 Atlantic Equities
Atlantic downgrades Coinbase to Neutral, lowers price target 'materially'
06/28/22 Compass Point
Compass Point upgrades Riot Blockchain to Buy while halving price target
06/23/22 B. Riley
Marathon Digital downgraded to Neutral at B. Riley amid sharp decline in Bitcoin
06/13/22 Morgan Stanley
Ethereum weakening faster than bitcoin, says Morgan Stanley
BITCOIN Bitcoin
/

+

07/06/22 Atlantic Equities
Atlantic downgrades Coinbase to Neutral, lowers price target 'materially'
06/28/22 Compass Point
Compass Point upgrades Riot Blockchain to Buy while halving price target
06/23/22 B. Riley
Marathon Digital downgraded to Neutral at B. Riley amid sharp decline in Bitcoin
06/13/22 Morgan Stanley
Ethereum weakening faster than bitcoin, says Morgan Stanley
$ETH Ethereum
/

+

06/13/22 Morgan Stanley
Ethereum weakening faster than bitcoin, says Morgan Stanley
05/19/22 Goldman Sachs
Any drag on spending from lower cryptocurrency prices 'very small,' says Goldman
02/04/22 New Street
Nvidia shares could hit $150 on 'crypto winter,' says New Street
BTC Bitcoin
/

+

$BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

$ETH Ethereum
/

+

HIVE Hive Blockchain
$3.23 /

-0.155 (-4.59%)

BTC Bitcoin
/

+

$BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

$ETH Ethereum
/

+

HIVE Hive Blockchain
$3.23 /

-0.155 (-4.59%)

Downgrade
FIH Mobile downgraded to Hold from Outperform at Daiwa » 05:06
07/07/22
07/07
05:06
07/07/22
05:06
FXCNY

FIH Mobile

$2.57 /

+ (+0.00%)

Daiwa analyst Kylie Huang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
EVgo initiated with a Hold at Jefferies » 05:04
07/07/22
07/07
05:04
07/07/22
05:04
EVGO

EVgo

$5.62 /

-0.115 (-2.01%)

Jefferies analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVGO EVgo
$5.62 /

-0.115 (-2.01%)

EVGO EVgo
$5.62 /

-0.115 (-2.01%)

06/08/22 Capital One
EVgo upgraded to Overweight from Equalweight at Capital One
05/16/22 Citi
EVgo price target lowered to $10 from $11 at Citi
05/12/22 Credit Suisse
Credit Suisse upgrades EVgo to Outperform with $14 price target
05/12/22 Credit Suisse
EVgo upgraded to Outperform from Neutral at Credit Suisse
EVGO EVgo
$5.62 /

-0.115 (-2.01%)

EVGO EVgo
$5.62 /

-0.115 (-2.01%)

EVGO EVgo
$5.62 /

-0.115 (-2.01%)

EVGO EVgo
$5.62 /

-0.115 (-2.01%)

Downgrade
Applied Molecular Transport downgraded to Hold from Buy at Jefferies » 05:04
07/07/22
07/07
05:04
07/07/22
05:04
AMTI

Applied Molecular Transport

$2.33 /

-0.8 (-25.56%)

Jefferies analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMTI Applied Molecular Transport
$2.33 /

-0.8 (-25.56%)

AMTI Applied Molecular Transport
$2.33 /

-0.8 (-25.56%)

05/19/22 JMP Securities
Applied Molecular Transport price target lowered to $50 from $86 at JMP Securities
AMTI Applied Molecular Transport
$2.33 /

-0.8 (-25.56%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.